Purchase Order 75N98026P01331

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed-price purchase order contract to Gene42 Inc. (doing business as Phenotips), a for-profit organization, to provide a PHENO TIPS CORE SUITE RENEWAL LICENSE. The contract has a potential value of $45,000.00 and a completion date of May 20, 2025. The place of performance is 2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada. This contract was not set aside for a...

<p>The National Cancer Institute awarded a purchase order to Genepria Consulting Inc. for $15,000 on August 28, 2019, with an ultimate completion date of September 1, 2020. Work is performed in Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The vendor provides scientific consultation and data analysis services in support of biomedical research programs, including algorithm development and imaging system support.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to Gene42 Inc. for $120,850 on August 18, 2017, to provide software development and support for the PhenoTips server deployed in the UDP Program at NIH/NHGRI. Work is performed in Ottawa, Ontario, Canada. The order is firm fixed price with an ultimate completion date of August 17, 2020.</p>

<p>The National Cancer Institute awarded a $15,000 purchase order to Genepria Consulting Inc. on August 28, 2018, for consulting and data analysis services in support of biomedical research. No set-aside applied. Work is performed in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of September 12, 2019.</p>

<p>The National Cancer Institute issued a delivery order to Genepria Consulting Inc. on August 16, 2018, with a ceiling value of $17,250.00 under firm fixed price terms.</p> <p>Place of performance is Bethesda, Maryland. The order was scheduled for ultimate completion on September 16, 2019. No set-aside was used for this delivery order.</p>

<p>The National Cancer Institute awarded a purchase order to Genepria Consulting Inc. for $15,000 on July 11, 2019, for laboratory and testing services. Performance location is Columbia, Maryland. The order carries firm fixed price terms and no set-aside designation. Ultimate completion was scheduled for July 11, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Rapid Novor Inc. for sequencing services valued at $21,000 on March 30, 2020. Work is performed at 2323 Riverside Drive, Ottawa, Ontario, Canada, with an ultimate completion date of April 17, 2021.</p>

The National Cancer Institute awarded a purchase order to Genepria Consulting Inc. for $23,598.00 on March 25, 2016, with ultimate completion on March 26, 2017. The order is firm fixed price with no set-aside. Performance occurs in Bethesda, Maryland. The awardee provides scientific consultation and data analysis services in support of biomedical research programs at the National Cancer Institute, including scientific input, algorithm development, and imaging support for cancer research...

<p>The National Cancer Institute awarded a purchase order to Genepria Consulting Inc. for $17,250.00 on August 2, 2018, for laboratory testing services. Work is performed in Columbia, Maryland. The order carries a firm fixed price structure with ultimate completion on September 16, 2019.</p>

<p>The National Cancer Institute awarded a $15,000 purchase order to Genepria Consulting Inc. on August 28, 2019, for algorithms supporting the study of multifunctional maps from EPRI, MRI, PET, and other imaging modalities, with completion by September 1, 2020. Work is performed in Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>